8 weeks of sofosbuvir/ledipasvir is effective in DAA-naive...

  • Main
  • 2018 / 12
  • 8 weeks of sofosbuvir/ledipasvir is effective in DAA-naive...

8 weeks of sofosbuvir/ledipasvir is effective in DAA-naive non-cirrhotic HCV genotype 4 infected patients (HEPNED-001 study)

Boerekamps, Anne, Vanwolleghem, Thomas, van der Valk, Marc, van den Berk, Guido E., van Kasteren, Marjo, Posthouwer, Dirk, Dofferhoff, Anthonius S.M., van Hoek, Bart, Ramsoekh, Dewkoemar, Koopsen, Jel
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Language:
english
Journal:
Journal of Hepatology
DOI:
10.1016/j.jhep.2018.10.032
Date:
December, 2018
File:
PDF, 296 KB
english, 2018
Conversion to is in progress
Conversion to is failed